TOX is a DNA-binding factor required for development of CD4 + T cells, natural killer T cells and regulatory T cells. Here we document that both natural killer (NK) cell development and lymphoid tissue organogenesis were also inhibited in the absence of TOX. We found that the development of lymphoid tissue-inducer cells, a rare subset of specialized cells that has an integral role in lymphoid tissue organogenesis, required TOX. Tox was upregulated considerably in immature NK cells in the bone marrow, consistent with the loss of mature NK cells in the absence of this nuclear protein. Thus, many cell lineages of the immune system share a TOX-dependent step for development.
A r t i c l e s
The immune system is composed of primary lymphoid organs, including thymus and bone marrow, which support the complex developmental programs necessary for the differentiation of precursor cells into distinct immune mediators, and secondary lymphoid organs, including spleen, lymph nodes and Peyer's patches, which focus antigens and promote the cellular interactions needed for the initiation of the adaptive immune response as well as the subsequent generation of effector functions. The development of lymph nodes and Peyer's patches, the latter consisting of lymph node-like structures located on the small intestine, occurs during embryogenesis through a complex series of interactions between hematopoietic and stromal cells involving both soluble and membrane-bound mediators 1 . The interaction of cell-bound lymphotoxin-α1β2 with the lymphotoxin-β receptor is important for this process 2 , such that ablation of lymphotoxin-α results in a complete lack of lymph nodes and Peyer's patches, as well as disorganized B cell and T cell areas in the spleen 3 . In addition, mice deficient in the chemokine CXCL13 or its receptor CXCR5 show a defect in Peyer's patches and have compromised lymph node formation 4 . An absence of interleukin 7 (IL-7) signaling through deletion of the IL-7 receptor (CD127) also inhibits secondary lymphoid tissue organogenesis, although to variable degrees [5] [6] [7] .
Key to the development of lymph nodes and Peyer's patches is a distinct subset of cells called lymphoid tissue-inducer (LTi) cells, which have been identified in both mice and humans 8, 9 . LTi cells are hematopoietic non-T cells (and thus express the leukocyte marker CD45 but lack rearrangement of T cell antigen receptor genes or expression of the invariant signaling complex CD3) that nonetheless have cell surface expression of CD4 in mice, whereas CD4 expression is heterogeneous in humans [8] [9] [10] . LTi cells also express CD127, CXCR5 and lymphotoxin-α, consistent with the disruption of lymphoid tissue development in mice deficient in the genes encoding these molecules 8, 11, 12 .
During fetal development, LTi cells concentrate as clusters in lymph node anlagen 8, 10, 13 . Transfer of fetal CD45 + CD3 − CD4 + cells into mice with severe defects in lymphoid tissue formation rescues these defects 11, 12 . IL-7 can promote new differentiation and proliferation of LTi cells from bone marrow in adult mice, which indicates that some precursors are retained after birth 14 . Indeed, LTi-like cells can be found in several lymphoid tissues in the adult mouse, including the thymus, spleen and gut. Adult and fetal LTi cells share most cell surface markers 14 , as well as a similar transcriptome 15 , and adult LTi cells can promote the development of intestinal lymphoid tissue positive for the stromal cell marker VCAM-1 when transferred into CXCR5-deficient mice 14, 15 . However, whether adult LTi cells can support true lymph node organogenesis remains to be formally demonstrated. Adult LTi cells have other roles in the immune system, including production of the inflammatory cytokines IL-17 and IL-22 (ref. 16 ), regulation of expression of the autoimmune regulator Aire by medullary thymic epithelial cells 17, 18 and organization of B cell and T cells areas in secondary lymphoid organs 18 .
The differentiation of LTi cells is dependent on several nuclear factors, such as Ikaros 19 , the E-protein inhibitor Id2 (refs. 20,21) and the transcription factor RORγ t 10 . Consequently, knockout of genes encoding these factors results in loss of LTi cells and the absence of peripheral lymph nodes and Peyer's patches 10, [20] [21] [22] . Notably, knockout of genes encoding two of these transcriptional regulators also affects the differentiation of natural killer (NK) cells. Thus, mice deficient in Ikaros or Id2 lack NK cells [19] [20] [21] and lymph nodes, which suggests the possibility of a common development pathway for these distinct cell types. 
The development of NK cells is dependent on expression of the IL-15 receptor 23 and the downstream IL-15-regulated basic leucine zipper transcription factor E4BP4 (NFIL3) 24, 25 . However, the block in NK cell development observed in IL-15 receptor-deficient or E4BP4-deficient mice occurs at an earlier stage than that in Id2-deficient mice 21, 24 . Overexpression of E4BP4 results in higher expression of Id2 in hematopoietic progenitor cells, which suggests that expression of Id2 could be directly regulated by E4BP4 (ref. 24) . Indeed, reconstitution of E4BP4-deficient mice with ectopically expressed Id2 restores the development of NK cells, which indicates that in this context E4BP4 functions mainly as an Id2 inducer. Whether the development of secondary lymphoid tissue is also inhibited in E4BP4-deficient mice has not yet been addressed. Thus, whether Id2 is similarly regulated during LTi cell development remains unclear.
In the present study we demonstrate that an additional nuclear protein, the DNA-binding factor TOX (thymocyte selection-associated highmobility group box protein), has a dual role in development of the NK and LTi lineages. Tox was initially identified on the basis of its upregulation during thymocyte differentiation, and it is expressed during specific stages of T cell development in the thymus 26 . TOX-deficient mice have a severe block at a transitional stage of positive selection in the thymus that leads to loss of the CD4 + T lymphocyte lineage 27 . We found that TOX was also expressed in LTi cells and at specific stages in the development of NK cells. Consistent with that, Tox −/− mice had few LTi cells, which led to failure of lymph node organogenesis and a much lower frequency and size of Peyer's patches. In addition, we found a cell-intrinsic defect in the ability of Tox −/− hematopoietic cells to differentiate into NK cells. Our data add another common link between the LTi and NK lineages and demonstrate TOX as a key participant in multiple aspects of immune system development.
RESULTS
Defective lymphoid organogenesis in the absence of TOX Tox −/− mice have a defect in the development of CD4 + T lineage cells 27 . In addition, all peripheral lymph nodes, including mesenteric lymph nodes, were absent from Tox −/− mice (Fig. 1a) . We have never found lymph nodes in over 100 Tox −/− mice ranging from 4 to 12 weeks of age. This phenotype was independent of the role of TOX in T cell development, as lymph nodes structures were present in mice with conditional T cell deletion of Tox, whereas the T cell-defect phenotype was recapitulated ( Supplementary Fig. 1 and J.K., unpublished observations).
We were able to identify Peyer's patches in the small intestine of some but not all Tox −/− mice. However, even when present, Peyer's patches were much smaller in size and much lower in frequency (Fig. 1b,c) . Histological analysis of the remaining Peyer's patches in Tox −/− mice demonstrated the presence of lymphocytes in these structures (Fig. 1d) and their organization in distinct B cell and T cell areas (Fig. 1e) . However, we noted some lower density of T cells (Fig. 1e ) that was probably due to the T lymphopenia of animals that lack TOX 27 . These results suggested that although the development of Peyer's patches was severely compromised in the absence of TOX, remaining structures could still be colonized by Tox −/− lymphocytes.
To address the issue of whether the loss of secondary lymphoid organs was caused by the abnormal complement of lymphocytes in Tox −/− mice, we generated bone marrow chimeras. Lymph nodes and Peyer's patches were present in all wild-type chimeric mice, whether they were reconstituted with donor bone marrow cells from Tox −/− mice (n = 6) or Tox +/− mice (n = 5). Moreover, like their Tox +/− counterparts, Tox −/− cells colonized both lymph nodes and Peyer's patches (Fig. 2a,b) , which challenged the possibility of a severe migration defect in cells that lack TOX. In addition, a T cell-intrinsic block in thymic positive selection 27 was evident in wild-type mice reconstituted with Tox −/− bone marrow because we found fewer CD4 + T cells in lymph nodes and Peyer's patches in these chimeric mice (Fig. 2a,b) . In contrast, Tox −/− mice reconstituted with wild-type bone marrow were still devoid of lymph nodes, and we did not detect any Peyer's patches in these mice (n = 8; data not shown).
The lack of lymph nodes in Tox −/− mice could also have been due to an inability of TOX-deficient cells to maintain lymph node primordia. For example, both alymphoplastic (aly/aly) mice and mice deficient in IL-2 receptor-γ and recombination-activating gene 2 have defects in lymph node formation; however, the former lack lymph nodes because of an absence of lymphotoxin signaling during embryogenesis, whereas the latter show a defect in the maintenance of the anlage due to the absence of mature lymphocytes required for crosstalk with these structures during the postnatal period 28 . Transfer of wild-type lymphocytes to neonates restores lymph nodes in the latter mice 28 , although the mechanism is unclear 29 . To address the possibility that transfer of wild-type lymphocytes would restore lymph A r t i c l e s node structures in TOX-deficient mice, we injected total lymph node cells derived from wild-type mice into Tox −/− mice within 24 h of birth. We detected donor wild-type T cells in the spleen of Tox −/− host mice 4 weeks after injection, and these were at a frequency similar to that in Tox +/− control host mice (Fig. 2c) . However, we did not detect lymph nodes in Tox −/− hosts ( Supplementary Fig. 2 ). Thus, we conclude that the absence of lymph nodes and loss of Peyer's patches in Tox −/− mice was probably caused by a defect in the generation of the primordia in the absence of TOX rather than the abnormal cellular environment in these mice.
Tox −/− mice lack LTi cells
The development of lymph nodes occurs during fetal development in both mice and humans and is dependent on CD4 + LTi cells (in mice). LTi cells home to specific areas in the mesentery during embryogenesis and, through interaction with mesenchymal cells, initiate organogenesis of rudimentary lymph node structures. We sought to determine if LTi cells were present in Tox −/− mice. Despite the fact that lymph node organogenesis is an embryonic process, we still detected LTi cells in the spleen of neonatal mice 15, 30, 31 (Fig. 3a) . However, in the absence of TOX, the average frequency and absolute number of LTi cells was over 90% lower ( Fig. 3a-c) . We also looked for fetal LTi cells in small intestine at embryonic day 18 (E18). Consistent with observations made with neonatal spleens, fetal LTi cells were significantly fewer and in many cases undetectable in the absence of TOX (Fig. 3d,e) . We obtained similar results with E18 fetal spleen, even when we did not use CD4 as a marker (data not shown).
We next sought to determine whether Tox was normally expressed in populations of LTi cells. To facilitate the isolation of LTi cells, we used splenocytes from mice deficient in the recombinase component RAG-1, which lack T cells and B cells, to minimize contamination from those lymphocyte subsets. We isolated CD45 + CD11c − CD3 − B220 − CD4 + CD127 + splenic LTi cells, reported to be functionally indistinguishable from embryonic LTi cells 30 and used them for gene-expression analysis. These cells expressed Id2 (Fig. 3f) and Rorc (encoding RORγ t; Fig. 3g ), which identified them as LTi cells 10, 21 . We detected Tox mRNA in this subset (Fig. 3h) , consistent with a cell-intrinsic defect in LTi cell development in the absence of TOX. Fetal LTi cells also expressed Rorc (Fig. 3i) and Tox (Fig. 3j) . Together these data indicate that the absence of lymph nodes was probably due to a cellintrinsic defect in the production of LTi cells in Tox −/− mice.
Because RORγ t has a role in the thymus as well as in LTi development 10, 22 , similar to TOX, we considered the possibility that RORγ t expression might be influenced by TOX. However, we did not observe any change in the expression of RORγ t in Tox −/− thymocytes relative to that in their wild-type counterparts by protein intracellular staining (Supplementary Fig. 3a) . This is consistent with the fact that mice deficient in RORγ t do not phenocopy Tox −/− mice in terms of the T cell developmental defect 22 . In addition, we assessed Rorc expression in reporter mice with knock-in of a cassette for green fluorescent protein in Rorc 10 and found similar Rorc expression in thymocytes from TOX-deficient and TOX-expressing cells (Supplementary Fig. 3b ).
Impaired NK cell development in Tox −/− mice Because LTi and NK cells share many commonalities in their development program, including dependence on Ikaros and Id2 factors, we investigated whether NK cell development was dependent on TOX. In the bone marrow, approximately 15% of lineage-negative (Lin − ) cells are mature NK cells that express the cell surface markers IL-2 receptor β-chain (CD122) and DX5 (Fig. 4a) . In the absence of TOX, the frequency of these cells was approximately 2% of that observed in wild-type mice (Fig. 4a) . To eliminate the possibility that the expression of CD122 was influenced by TOX, we additionally used antibodies to the markers NK1.1 and DX5 or NKp46 and CD122 to stain Lin − cells in the bone marrow ( Fig. 4a and data not shown) and spleen ( Supplementary Fig. 4a ). We obtained similar results when we used these staining strategies ( Fig. 4a and Supplementary Fig. 4a,b) .
In the Lin − CD122 + bone marrow cell population, the same markers used above can also be used to identify NK cell developmental stages 21 A r t i c l e s subsets were still present (with a trend toward fewer iNK cells), the mNK subpopulation was much smaller in the absence of TOX (Fig. 4a,b) . The inhibition of NK cell development was also apparent in the spleen of Tox −/− mice (Fig. 4c) , in which the frequency and absolute number of NK cells were approximately 97% lower than those of their wild-type counterparts (Fig. 4d) .
To determine if the inhibition of NK cell development could have been due to a cell-intrinsic defect, we purified NK cell developmental T subsets from the bone marrow and spleen of wild-type mice and analyzed Tox expression. We used splenic B cells, which do not express TOX and are not developmentally affected by loss of TOX 27 , as a biological negative control. We detected small amounts of Tox mRNA in both bone marrow NKp and splenic NK subsets (Fig. 4e) , whereas both the iNK and mNK subsets from bone marrow had high expression of Tox (Fig. 4e) . The upregulation of Tox at the iNK and mNK stages was consistent with the observed block in NK cell development in the absence of TOX (Fig. 4a,b) . The finding that Tox was further downregulated in splenic mNK cells compared with its expression in bone marrow mNK cells may be an indication of continued maturation of these cells or additional microenvironmental or cell-subset differences.
We isolated a small number of bone marrow mNK cells from Tox −/− mice and assessed if they expressed Id2, a gene essential for development of the NK cell lineage that is expressed subsequent to the NKp stage 21 . Notably, Tox −/− bone marrow mNK cells had lower expression of Id2 than did their wild-type counterparts (Fig. 4f) . This suggests that either the induction or the maintenance of Id2 expression is influenced by TOX or that the NK cell-lineage development block in Tox −/− mice occurs before full upregulation of Id2.
As shown above (Fig. 4c) , we were able to detect some mature NK cells in the spleen of Tox −/− mice. To determine if these remaining NK cells were functional, we did a cytolytic assay for NK activity in vivo, taking advantage of the fact that NK cells but not CD8 + T cells would kill otherwise syngeneic major histocompatibility complex (MHC) class I-negative targets 34 . Thus, we injected control or Tox −/− mice with a mixture of wild-type and β 2 -microglobulin-deficient target cells labeled with different amounts of the cytosolic dye CFSE (CFSE lo (wild-type) or CFSE hi (β 2 -microglobulin-deficient)) and analyzed the ratio of recovered target cells from the spleen 16 h later. The specific killing of β 2 -microglobulin-deficient target cells by Tox −/− hosts was approximately two-thirds lower than the killing activity of Tox +/− control hosts (Fig. 4g) . This is consistent with the loss of mature NK cells from TOX-deficient mice. However, these data also suggest that NK cells that escape the developmental block maintain at least some effector function even in the absence of TOX.
Cell-intrinsic requirement for TOX in NK cell development
To further study the cell-intrinsic role of TOX in developing NK cells, we made use of a stromal cell-free cell culture system that can support NK cell development from hematopoietic progenitor cells 35 . In this two-step system, a cytokine 'cocktail' induces CD122 + NKp cells after 6 d of culture, which further develop into NK1. (Fig. 5a) . These results recapitulated the in vivo phenotype of Tox −/− mice.
Both Tox +/− and Tox −/− bone marrow precursor cells produced progeny with similar expression of CD122 (Fig. 5b) , which challenged the idea of a defect in the differentiation or proliferation in Tox −/− progenitor cells in the primary culture. To further test the proliferative capacity of Tox −/− progenitors, we mixed highly purified, phenotypically marked wild-type and Tox −/− LSK cells at a ratio of 1:1 and analyzed their population expansion after the 6 d of culture (Fig. 5c) . Tox −/− cells underwent greater population expansion than did wild-type cells in these cultures, which indicated that there was no initial proliferative defect in the absence of TOX. Together these data are consistent with a requirement for TOX subsequent to the progenitor stage of NK cell development in the bone marrow, and they are also consistent with the peak of Tox expression in iNK cells.
We also considered the possibility that Tox −/− bone marrow progenitors had undergone irreversible lineage commitment before isolation, possibly as a result of altered cellular niches. However, in vitro NK cell development was restored after retrovirus-mediated expression of TOX in Tox −/− progenitors (Fig. 6a) . In addition, TOX expression boosted the NK cell output from Tox +/− LSK cells compared with that of Tox +/− LSK cells infected with a control recombinant virus expressing the H-2K b MHC molecule. This may suggest either that TOX is limiting in mice heterozygous for knockout of Tox or that sustained or higher TOX expression can promote the NK cell fate.
Id2, like TOX, is required for both LTi and NK cell development 20, 21, 36 . In addition, E4BP4, which is also required for NK cell development, is upregulated directly or indirectly as a consequence of IL-15-mediated signaling and is an upstream Id2 regulator 24 . Because mNK cells isolated from Tox −/− bone marrow had lower expression of Id2 (Fig. 4f) , we assessed whether expression of Id2 could compensate for loss of TOX as it does for loss of E4BP4 (ref. 24). Id2 expression was not able to restore NK cell development from Tox −/− bone marrow progenitors (Fig. 6b) . However, Id2 expression was able to efficiently inhibit the modest B cell production of these cultures (Fig. 6c) , as expected due to the requirement for E-protein activity during B cell development 37 . These data demonstrate that the requirement for TOX in NK cell development cannot be attributed solely to control of Id2 and may indicate the presence of an additional regulatory pathway required for the development of both NK and LTi cell subsets. 
A r t i c l e s

DISCUSSION
Here we have demonstrated an essential role for TOX in the formation of peripheral lymph nodes and Peyer's patches. The development of secondary lymphoid tissue is a complex process that involves both mesenchymal and hematopoietic cells. In the case of Peyer's patch development, two cell types of hematopoietic origin are involved: LTi cells and CD4 − CD11c + cells (the latter being distinct from splenic dendritic cells) 38 . Whether these CD11c + cells also have a role in lymph node development is not known. Here we have shown that in the absence of TOX, both fetal and neonatal mice were depleted of LTi cells. In addition, both fetal and adult LTi cells normally expressed Tox. Thus, these results suggest that a defect in LTi cell production in the absence of TOX leads to the failure of normal secondary lymphoid tissue development. We have also shown that TOX is required for the development of NK cells. TOX is thus the third nuclear factor described as having a role in the development of both cell lineages, along with Ikaros and Id2. Deletion of TOX or Id2 results in a similar phenotype in NK cell and secondary lymphoid tissue development. In terms of the latter, both TOX and Id2 seem to regulate a developmental stage subsequent to pNK cell differentiation 21 . However, we detected some Peyer's patch structures, albeit scarcer and smaller than normal, in the absence of TOX, whereas Id2 −/− mice lack Peyer's patches completely 20, 21 . Whether this difference relates to detection sensitivities or to a true difference in the 'leakiness' of the two phenotypes remains to be determined.
There are differences between Peyer's patches and lymph nodes in their embryonic development. These include earlier embryonic development and reliance on TRANCE signaling for the latter 39, 40 , whereas loss of the IL-7 receptor (CD127) leads mainly to an absence of Peyer's patches 41, 42 . A narrowed developmental window or a particularly stringent requirement for a full complement of LTi cells in lymph node development could explain the complete loss of these structures in Tox −/− mice, in contrast to the presence of some small Peyer's patches in these mice.
Despite their lack of lymph nodes, a small number of LTi-like cells can be identified in adult Tox −/− mice (J.K., unpublished observations). Adult LTi-like cells have other functions in the immune system, including the production of IL-17 and IL-22, the development of Aire + epithelial cells in the thymic medulla and the maintenance and organization of secondary lymphoid organs [16] [17] [18] . It will thus be useful to determine if lack of TOX also affects these functions.
NK cell development is highly dependent on IL-15 signaling and thus on expression of the IL-15 receptor 23 . However, the in vitro development of CD122 + NKp cells from TOX-deficient hematopoietic precursors demonstrated that the inhibition of NK cell development in the absence of TOX was not caused by a failure to express CD122. In the thymus, TOX expression is dependent on T cell antigen receptor-mediated activation of calcineurin 43 . It has been argued that expression of E4BP4, and thus of Id2, is downstream of IL-15 signaling 24 . Whether TOX is similarly regulated in this cell context remains to be determined.
Id2 was also upregulated after positive selection in the thymus, and TOX expression preceded Id2 expression during thymocyte progression through transitional stages of development (J.K., unpublished observations). However, Id2 −/− mice do not show the defect in T cell development seen in mice that lack TOX, although compensatory effects by the related factor Id3 cannot be ruled out 36 . Although Tox −/− bone marrow NK cells had lower expression of Id2 mRNA, we found that ectopic expression of Id2 was not able to restore NK cell development in the absence of TOX, as had been observed for the NK lineage factor E4BP4 (ref. 24) . Although the exact relationship between TOX and Id2, if any, remains to be further elucidated, it is clear that the role of TOX in NK cell development is not solely as an upstream regulator of Id2.
The NK and LTi lineages have some notable commonalities, although the exact developmental relationship between these cell types is still unclear. It is known that neonatal CD45 + CD4 + CD3 − mesenteric lymph nodes cells cultured in limiting-dilution conditions in the presence of IL-2 and stromal cells produce NK1.1 + colonies with cytolytic activity 8 . This result is particularly notable given data characterizing NK-like and LTi-like cells in the gut. Socalled 'LTi-like' Lin − CD4 + CD127 + CD3 − cells can be found in the spleen and intestinal lamina propria in mice, and these cells produce IL-17 and IL-22 and express RORγ t 16, 44 . Similarly, there is a CD127 + subset of LTi-like cells that can give rise to an IL-15-independent but RORγ t-and Id2-dependent NKp46 + CD3 − population found in the gut that also produces . Cell subsets with similar properties are also found in humans 9, 48 . We have observed that some NKp46 + CD3 − RORγ t + cells were still present in the small intestine of Tox −/− mice (data not shown), consistent with data showing that these cells are distinct from both LTi cells and the main NK cell lineage 9, [46] [47] [48] . However, given the abnormal lymphocyte environment in Tox −/− mice, which could influence the population expansion of these cells, comparative quantification relative to normal mice is problematic, and earlier progenitor cell populations have not been well defined. Thus, we cannot formally rule out the possibility of a role for TOX in the development of these distinct NK-like cell subsets. Although the exact relationship between LTi and NK cell subpopulations and their precursors awaits additional clarification, the addition of TOX to the short list of known transcriptional regulators of LTi and NK cell lineages provides a new tool for addressing these issues.
TOX seems to have a nonredundant function in three aspects of development of the immune system: CD4 + T cell development, NK cell development and LTi cell development. Somewhat analogous to the pattern of TOX expression during positive selection of thymocytes, Tox expression in the NK lineage is transiently upregulated during a key developmental transition. Indeed, the highest expression of TOX is predictive of the observed developmental block. Among thymocytes, CD4 + CD8 lo thymocytes have high Tox expression and TOX is required for their development 26, 27 ; in the bone marrow, iNK cells have high Tox expression and TOX is required for their continued development. Whether there is a similar pulse of expression during a specific stage of LTi development in the fetus is thus of interest. In sum, our data have identified TOX as an essential regulator of the development of multiple facets of the adaptive immune system and have added another commonality to the developmental pathways of NK cells and LTi cells.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
